Notice2025-03973
Center for Scientific Review; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 13, 2025
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 48 (Thursday, March 13, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 48 (Thursday, March 13, 2025)]
[Notices]
[Page 11994]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-03973]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-NS-22-025: Helping to End Addiction Long-Term (HEAL) K99.
Date: April 2, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Devaiah Nanjappa Ballachanda, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 801F, Bethesda, MD 20892, (301)
480-0576, <a href="/cdn-cgi/l/email-protection#751714191914161d141b1114113518141c195b1b1c1d5b121a03"><span class="__cf_email__" data-cfemail="284a494444494b4049464c494c684549414406464140064f475e">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Cancer Immunology and Immunotherapy II.
Date: April 8, 2025.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Ola Mae Zack Howard, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192, MSC 7806, Bethesda, MD
20892, 301-451-4467, <a href="/cdn-cgi/l/email-protection#6a02051d0b180e102a070b030644040302440d051c"><span class="__cf_email__" data-cfemail="5b33342c3a293f211b363a323775353233753c342d">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-OD-25-002: Investigation of Co-occurring conditions
across the Lifespan to Understand Down syndrome (INCLUDE).
Date: April 8, 2025.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Devaiah Nanjappa Ballachanda, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 801F, Bethesda, MD 20892, (301)
480-0576, <a href="/cdn-cgi/l/email-protection#f193909d9d909299909f959095b19c90989ddf9f9899df969e87"><span class="__cf_email__" data-cfemail="3c5e5d50505d5f545d52585d587c515d555012525554125b534a">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Cancer Immunology and Immunotherapy I.
Date: April 23-24, 2025.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Ola Mae Zack Howard, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192, MSC 7806, Bethesda, MD
20892, 301-451-4467, <a href="/cdn-cgi/l/email-protection#85edeaf2e4f7e1ffc5e8e4ece9abebecedabe2eaf3"><span class="__cf_email__" data-cfemail="650d0a120417011f2508040c094b0b0c0d4b020a13">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Cardiovascular Differentiation and Development.
Date: April 29, 2025.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Sara Ahlgren, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, RM 4136, Bethesda, MD 20892, 301-435-0904,
<a href="/cdn-cgi/l/email-protection#c1b2a0b3a0efa0a9ada6b3a4af81afa8a9efa6aeb7"><span class="__cf_email__" data-cfemail="0b786a796a256a63676c796e654b656263256c647d">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 7, 2025.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-03973 Filed 3-12-25; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 13, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.